Supply Chain

The FDA launched a more accessible dashboard for its adverse event reporting system, the database that contains medication errors and product quality complaints, the agency said Sept. 28.

A U.S. District Court judge denied the generic drug industry trade group's request for a preliminary injunction of Maryland's law that penalizes drugmakers for price gouging —allowing the state law to take effect, according to Reuters.

Hundreds of people lined up outside of Las Vegas blood banks in the hours after a gunman opened fire on the Vegas strip, killing at least 50 people and injuring more than 400, reports The Hill.

An oncology drug trial halted after a patient death most captured the attention of readers in September.

Here are five drug and medical device companies that made headlines in the past week.

As healthcare shifts toward a more consumer-centric approach, some hospitals are developing their own mail order pharmacies to ship prescriptions right to patients' doors.

Camp Hill, Pa.-based Rite Aid appointed Kermit Crawford, former executive vice president and president of pharmacy health and wellness for Deerfield, Ill.-based Walgreens, president and COO of Rite Aid, effective Oct. 5.

Here are the three latest drugs or medical devices approved by the Food and Drug Administration in the past week.

Amgen on Thursday settled a patent lawsuit with Abbvie over its biosimilar version of Abbvie's best-selling arthritis drug Humira, reports Reuters.

The Food and Drug Administration on Wednesday approved Abbott's FreeStyle Libre Flash Glucose Monitoring System.